PAVmed plans to license Duke’s oesophageal imaging technology
PAVmed has signed a non-binding letter of intent with Duke University to license an oesophageal imaging technology.| Medical Device Network
UK-based Cyted Health has raised $44m to accelerate the ongoing market adoption of its EndoSign device in the US. The post Cyted raises $44m to propel US market expansion of its endoscopic capsule appeared first on Medical Device Network.| Medical Device Network
Foresight Diagnostics has announced a licencing agreement with Roche concerning its Phased variant Enrichment PhasED-Seq technology The post Foresight and Roche sign licensing deal for PhasED-Seq technology appeared first on Medical Device Network.| Medical Device Network
Abiomed has initiated a voluntary recall for certain Automated Impella Controllers (AICs) used in conjunction with its Impella catheters following reports of one death as of 12 August in relation to a capacitor failure with the controllers’ interface. The post FDA flags Abiomed’s latest recall as Impella pump woes continue appeared first on Medical Device Network.| Medical Device Network
UK-based battery developer Ilica has completed the necessary validation steps for its Stereax M300 micro-battery production line at manufacturing partner Cirtec Medical’s facility in Massachusetts. The post Ilica completes micro-battery qualification with Cirtec Medical appeared first on Medical Device Network.| Medical Device Network
Neusoft Medical Systems has launched its NeuViz P10 PCCT system in China, targeting advanced medical imaging applications. The post Neusoft Medical introduces NeuViz P10 PCCT system in China appeared first on Medical Device Network.| Medical Device Network
Natera said that its Signatera test will be utilised in the newly activated ARCHER trial, a Phase III study sponsored by NRG Oncology. The post Natera’s Signatera test to be used in Phase III bladder cancer trial appeared first on Medical Device Network.| Medical Device Network
A new study by a research team comprising experts from Johns Hopkins University (JHU) and the University of Yale has demonstrated that the early signs of amyotrophic lateral sclerosis (ALS) can be detected with a blood test up to a decade before the disease’s traditional clinical symptoms emerge. The post Blood test able to detect ALS up to a decade before symptoms start appeared first on Medical Device Network.| Medical Device Network
Safeguards against the appearance of AI consciousness is needed to protect against 'AI psychosis', says Dr. Hamilton Morrin. The post AI psychosis sees users ‘co-creating delusions with technology’ – expert appeared first on Medical Device Network.| Medical Device Network
As approaches to treating cancer continue becoming more targeted, an expert has said companion diagnostics (CDx) have an increasingly important role to play in oncology. The post Shift towards precision oncology catalysing CDx market appeared first on Medical Device Network.| Medical Device Network
PAVmed has signed a non-binding letter of intent with Duke University to license an oesophageal imaging technology.| Medical Device Network
I would also like to subscribe to:| Medical Device Network
The European Patent Office (EPO) has granted patent no. 3,697,298 to Autonomix Medical’s catheter-based technology| Medical Device Network
The rise of agentic artificial intelligence (AI) is liable to have multiple use cases for healthcare in patient-facing areas including remote monitoring, but it will also bring new legal considerations along with it, an expert says.| Medical Device Network
The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.| Medical Device Network
The US Federal Trade Commission (FTC) is suing Edwards Lifesciences to stop it from acquiring JenaValve, citing anticompetitive concerns.| Medical Device Network
A key trend in the medical device market is smaller and smarter, which requires advanced materials and is the focus of the latest podcast from Alleima Medical.| Medical Device Network
The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.| Medical Device Network
To realise the potential of medical device data and maintain security protocols in a more connected medtech reality, network architecture must evolve.| Medical Device Network
Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas Wearable Injector for subcutaneous delivery of biologics.| Medical Device Network
Becton, Dickinson and Company (BD) has announced its submission of an application to the FDA for an at-home human papillomavirus (HPV) test.| Medical Device Network
The use of artificial intelligence (AI) and generative AI (GenAI) in the healthcare space is skyrocketing.| Medical Device Network
Axonius has acquired New York-headquartered healthcare cybersecurity firm Cynerio in a $100m cash and stock deal.| Medical Device Network
How can medical device companies improve the sustainability of clinical products?| Medical Device Network
Discover the leading Medical Plastics Manufacturers for the Medical Industry. Download the free Buyer's Guide today for full contact detials.| Medical Device Network
Discover leading Sales & Marketing Intent Data Solutions for the medical device industry. Download the free Buyer's Guide for full details.| Medical Device Network
AI technologies are pushing the boundaries of what constitutes a medical device. Historically, a medical device was defined by its physical characteristics and intended use, but AI introduces complexities that challenge this traditional framework.| Medical Device Network
Firefly Neuroscience is now a non-exclusive distributor for Zeto’s pair of EEG-headsets, called WR19 and Zeto ONE.| Medical Device Network
CVRx has reported durable improvements in heart failure patients with its Barostim device over 24 months.| Medical Device Network
The Class I recall was issued following reports of false negative responses and was linked with 10 reported injuries.| Medical Device Network
Abbott has entered a partnership to integrate its FreeStyle Libre CGM technology with smart insulin pen systems of Medtronic.| Medical Device Network
